Stock listing
Shanghai:688321 Shenzhen Chipscreen Biosciences Co. Ltd. (微芯生物) 股价
Follow Shenzhen Chipscreen Biosciences Co. Ltd. into a list and get an email when it puts out news.
Share price · SSE:688321
¥16.54 CNY -2.20 (-11.7%)
Close on Nov 20, 2026
- Day range
- ¥16.52 – ¥17.60 CNYNov 20, 2026
- Volume
- 10.09M sharesNov 20, 2026
- Market cap
- ¥7.33B CNYAt the close on Nov 20, 2026 · price × 442.9M shares outstanding
- 52-week range
- ¥16.52 – ¥36.47 CNYLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ¥196.2M CNYMedian day 7.06M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SSE:688321 · CNY, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ¥16.54 | -2.20 | -11.7% | ¥17.31 | ¥17.60 | ¥16.52 | 10,093,450 | |
| ¥18.74 | -0.36 | -1.9% | ¥19.09 | ¥19.27 | ¥18.30 | 7,585,843 | |
| ¥19.10 | -0.60 | -3.0% | ¥19.73 | ¥19.84 | ¥19.00 | 6,566,484 | |
| ¥19.70 | -0.53 | -2.6% | ¥20.25 | ¥20.43 | ¥19.62 | 5,647,092 | |
| ¥20.23 | -0.93 | -4.4% | ¥21.20 | ¥21.38 | ¥20.14 | 5,923,702 | |
| ¥21.16 | -0.18 | -0.8% | ¥21.34 | ¥21.59 | ¥21.12 | 4,977,748 | |
| ¥21.34 | +0.09 | +0.4% | ¥21.24 | ¥21.38 | ¥20.89 | 4,387,661 | |
| ¥21.25 | +0.25 | +1.2% | ¥21.31 | ¥21.37 | ¥21.00 | 4,362,056 | |
| ¥21.00 | -0.12 | -0.6% | ¥21.46 | ¥21.48 | ¥21.00 | 4,307,021 | |
| ¥21.12 | -0.27 | -1.3% | ¥20.96 | ¥21.58 | ¥20.79 | 5,953,549 | |
| ¥21.39 | +0.59 | +2.8% | ¥20.80 | ¥21.64 | ¥20.71 | 8,086,007 | |
| ¥20.80 | +1.02 | +5.2% | ¥19.92 | ¥20.95 | ¥19.78 | 9,642,083 | |
| ¥19.78 | -0.32 | -1.6% | ¥20.07 | ¥20.28 | ¥19.65 | 6,576,739 | |
| ¥20.10 | +0.24 | +1.2% | ¥19.93 | ¥20.22 | ¥19.41 | 8,802,066 | |
| ¥19.86 | -0.29 | -1.4% | ¥20.00 | ¥20.96 | ¥19.73 | 8,147,307 | |
| ¥20.15 | -0.40 | -1.9% | ¥20.33 | ¥20.44 | ¥19.77 | 8,226,868 | |
| ¥20.55 | -0.97 | -4.5% | ¥21.20 | ¥21.36 | ¥19.80 | 13,090,314 | |
| ¥21.52 | -1.02 | -4.5% | ¥22.70 | ¥22.88 | ¥21.51 | 5,989,554 | |
| ¥22.54 | -0.14 | -0.6% | ¥22.65 | ¥22.82 | ¥22.22 | 4,366,426 | |
| ¥22.68 | +0.50 | +2.3% | ¥22.02 | ¥22.80 | ¥21.46 | 7,879,513 | |
| ¥22.18 | -0.41 | -1.8% | ¥22.60 | ¥23.46 | ¥22.18 | 6,686,907 | |
| ¥22.59 | +0.21 | +0.9% | ¥22.58 | ¥23.03 | ¥22.45 | 4,355,699 | |
| ¥22.38 | +0.59 | +2.7% | ¥21.80 | ¥22.45 | ¥21.57 | 5,555,893 | |
| ¥21.79 | -0.01 | 0.0% | ¥21.64 | ¥22.10 | ¥21.43 | 5,217,661 | |
| ¥21.80 | -0.13 | -0.6% | ¥22.34 | ¥22.77 | ¥21.56 | 7,188,528 | |
| ¥21.93 | -0.03 | -0.1% | ¥21.77 | ¥22.50 | ¥21.45 | 6,784,305 | |
| ¥21.96 | -0.84 | -3.7% | ¥22.66 | ¥22.87 | ¥21.96 | 6,328,870 | |
| ¥22.80 | -0.82 | -3.5% | ¥23.48 | ¥23.48 | ¥22.31 | 8,753,373 | |
| ¥23.62 | -0.69 | -2.8% | ¥24.40 | ¥24.49 | ¥23.52 | 5,838,755 | |
| ¥24.31 | +0.25 | +1.0% | ¥23.97 | ¥24.45 | ¥23.56 | 8,494,908 | |
| ¥24.06 | -1.16 | -4.6% | ¥25.30 | ¥25.62 | ¥23.90 | 10,864,125 | |
| ¥25.22 | +0.30 | +1.2% | ¥24.85 | ¥25.85 | ¥24.85 | 8,068,655 | |
| ¥24.92 | -0.29 | -1.2% | ¥25.22 | ¥25.73 | ¥24.83 | 6,160,112 | |
| ¥25.21 | -0.14 | -0.6% | ¥25.40 | ¥25.59 | ¥24.82 | 7,812,107 | |
| ¥25.35 | -0.83 | -3.2% | ¥26.10 | ¥26.37 | ¥25.18 | 8,665,653 | |
| ¥26.18 | -0.13 | -0.5% | ¥26.54 | ¥26.62 | ¥26.15 | 7,537,794 | |
| ¥26.31 | +0.08 | +0.3% | ¥26.10 | ¥26.70 | ¥26.00 | 10,630,933 | |
| ¥26.23 | +1.21 | +4.8% | ¥25.26 | ¥26.64 | ¥25.20 | 16,674,198 | |
| ¥25.02 | +0.44 | +1.8% | ¥24.79 | ¥25.18 | ¥24.63 | 6,927,445 | |
| ¥24.58 | +0.14 | +0.6% | ¥24.40 | ¥24.94 | ¥24.40 | 5,418,164 | |
| ¥24.44 | +0.39 | +1.6% | ¥24.02 | ¥24.49 | ¥23.94 | 5,492,343 | |
| ¥24.05 | -0.22 | -0.9% | ¥24.26 | ¥24.44 | ¥24.00 | 2,946,104 | |
| ¥24.27 | +0.59 | +2.5% | ¥23.60 | ¥24.35 | ¥23.46 | 5,829,546 | |
| ¥23.68 | -0.82 | -3.3% | ¥24.48 | ¥24.48 | ¥23.44 | 8,837,354 | |
| ¥24.50 | -0.43 | -1.7% | ¥24.91 | ¥24.91 | ¥24.24 | 6,069,964 | |
| ¥24.93 | -0.48 | -1.9% | ¥25.30 | ¥25.39 | ¥24.88 | 6,496,697 | |
| ¥25.41 | +0.06 | +0.2% | ¥25.35 | ¥25.52 | ¥25.10 | 6,340,392 | |
| ¥25.35 | +0.17 | +0.7% | ¥25.35 | ¥25.53 | ¥25.00 | 5,003,315 | |
| ¥25.18 | -0.11 | -0.4% | ¥25.55 | ¥25.75 | ¥25.10 | 6,768,989 | |
| ¥25.29 | +0.42 | +1.7% | ¥25.10 | ¥25.44 | ¥24.92 | 6,567,104 | |
| ¥24.87 | -0.60 | -2.4% | ¥25.40 | ¥25.48 | ¥24.82 | 10,407,044 | |
| ¥25.47 | +0.05 | +0.2% | ¥25.39 | ¥25.65 | ¥25.14 | 7,387,803 | |
| ¥25.42 | -0.41 | -1.6% | ¥25.51 | ¥25.60 | ¥25.03 | 9,417,644 | |
| ¥25.83 | -0.36 | -1.4% | ¥26.17 | ¥26.52 | ¥25.80 | 8,167,332 | |
| ¥26.19 | +0.44 | +1.7% | ¥25.76 | ¥26.19 | ¥25.25 | 10,674,113 | |
| ¥25.75 | -0.13 | -0.5% | ¥25.80 | ¥26.35 | ¥25.54 | 9,854,377 | |
| ¥25.88 | -0.01 | 0.0% | ¥25.78 | ¥26.09 | ¥25.25 | 11,880,348 | |
| ¥25.89 | -2.06 | -7.4% | ¥27.87 | ¥28.03 | ¥25.84 | 20,469,750 | |
| ¥27.95 | -2.00 | -6.7% | ¥29.59 | ¥29.95 | ¥27.83 | 20,890,261 | |
| ¥29.95 | +1.09 | +3.8% | ¥30.30 | ¥31.88 | ¥29.70 | 28,135,821 |
- Ticker
- Shanghai:688321
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Shanghai
- Currency
- CNY
What changed lately
Latest news release · Nov 18, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction
Latest news
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction
Nov 18, 2026
Closed ¥18.74 (-1.9%) on Nov 18, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Not Revising the Conversion Price of "Chipscreen Convertible Bonds" Downward
Nov 17, 2026
Closed ¥19.10 (-3.0%) on Nov 17, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of the Renewed Inclusion of the Company's Product in the National Reimbursement Drug List
Nov 16, 2026
Closed ¥19.70 (-2.6%) on Nov 16, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS231295 Tablets
Nov 14, 2026
Closed ¥19.70 (-2.6%) on Nov 16, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Indicative Announcement on "Chipscreen Convertible Bonds" Expected to Meet Conditions for Revising Conversion Price
Nov 10, 2026
Closed ¥21.25 (+1.2%) on Nov 10, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Holding Unrestricted Shares Concerning Share Repurchase
Nov 10, 2026
Closed ¥21.25 (+1.2%) on Nov 10, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Share Repurchase Proposal through Call Auction and Receipt of Commitment Letter for Special Loan for Share Repurchase from Financial Institution
Nov 6, 2026
Closed ¥21.12 (-1.3%) on Nov 6, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Resolutions of the 32nd Meeting of the 3rd Board of Directors
Nov 6, 2026
Closed ¥21.12 (-1.3%) on Nov 6, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Proposal from the Chairman for Share Repurchase
Oct 30, 2026
Closed ¥19.86 (-1.4%) on Oct 30, 2026
(688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Report for Q3 2026
Oct 28, 2026
Closed ¥20.55 (-4.5%) on Oct 28, 2026
Shenzhen Chipscreen Biosciences Co. Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 66 in the last 12 months · 86 in all · newest Nov 18, 2026 · oldest 2025
Valuation
P/E 102× against a median of 14.6×: the highest of 2 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ¥7.32B CNY
- P/E
- 102×
- EV/sales
- 6.8×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 2.9×
- Gross margin
- 97.5%
- Operating margin
- 11.1%
- Net margin
- 6.6%
- Debt to equity
- 0.5×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Shenzhen Chipscreen Biosciences Co. Ltd. Class A · SSE:688321 | US$1.10B | US$1.10B | 102× | 6.8× | n/a | 2.9× | 6.6% | 0.5× | n/a |
| D&D Pharmatech Co., Ltd. · KRX:347850 | US$1.15B | US$1.12B | n/a | 549× | n/a | 11.5× | −785.5% | 0.8× | n/a |
| Structure Therapeutics, Inc. · NASDAQ:GPCR | US$1.15B | −US$82.92M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | 1.38 |
| COMPASS Pathways Plc · NASDAQ:CMPS | US$1.14B | US$747.8M | n/a | n/a | n/a | 8.0× | n/a | 0.4× | 1.65 |
| Ascentage Pharma Group International · HKEX:6855 | US$1.11B | US$1.14B | n/a | 13.6× | n/a | 13.3× | −216.5% | 3.8× | n/a |
| Pharma Mar SA · BME:PHM | US$1.10B | US$978.5M | 14.6× | 3.8× | 16.6× | 4.2× | 28.8% | 0.3× | n/a |
| Alpha Tau Medical Ltd · NASDAQ:DRTS | US$1.09B | US$1.00B | n/a | n/a | n/a | 55.3× | n/a | 0.8× | 1.89 |
| Kardigan, Inc. · NASDAQ:KARD | US$1.08B | US$621.1M | n/a | n/a | n/a | 1.9× | n/a | 0.0× | n/a |
| PYC Therapeutics Limited · ASX:PYC | US$1.07B | US$775.8M | n/a | n/a | n/a | 2.3× | n/a | 0.0× | n/a |
| Jade Biosciences, Inc. · NASDAQ:JBIO | US$1.06B | US$583.6M | n/a | n/a | n/a | 2.3× | n/a | 0.0× | 1.14 |
| MedinCell SA · EURONEXT:MEDCL | US$1.05B | US$1.02B | n/a | 38.4× | n/a | 313× | −128.9% | 18.7× | n/a |
| Median of the others | US$1.09B | US$877.2M | 14.6× | 26.0× | 16.6× | 6.1× | −172.7% | 0.3× | 1.52 |
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 32.68 CNY · Analysts' mean
- Revenue, year to Dec 2024
- 706M · 1 analyst
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2023 | Aug 11, 2023 · Before open | −0.6% |
| Q1 2023 | Apr 27, 2023 · After close | −9.1% |
| Q4 2022 | Feb 27, 2023 · Before open | −1.1% |
| Q3 2022 | Oct 28, 2022 · Before open | −4.6% |
| Q2 2022 | Aug 22, 2022 · After close | −6.0% |
| Q1 2022 | Apr 29, 2022 · Before open | +4.7% |
| Q4 2021 | Feb 25, 2022 · After close | +2.1% |
| Quarter to Sep 30, 2021 | Oct 29, 2021 · Before open | +0.1% |
| Quarter to Jun 30, 2021 | Aug 29, 2021 · After close | −2.2% |
| Quarter to Mar 31, 2021 | Apr 30, 2021 · Before open | −1.4% |
All 11 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Dec 31, 2020 | Feb 26, 2021 · Before open | +0.5% |
Financings
| Raise | Date |
|---|---|
| Private placement of a-shares Update: private placement | Dec 3, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CNY
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 909.5M | 657.9M | 523.7M | 529.9M | 430.4M | 269.5M | 173.8M | 147.7M | 110.5M | 85.4M |
| Cost of revenue | 117.2M | 87.5M | 57.0M | 30.0M | 21.6M | 13.5M | 7.29M | 5.51M | 5.33M | 2.17M |
| Gross profit | 909.5M | 570.5M | 466.7M | 499.9M | 408.9M | 256.0M | 166.5M | 142.2M | 105.2M | 83.2M |
| Research and development | 221.6M | 214.5M | 270.4M | 163.7M | 130.0M | 92.3M | 51.4M | 43.2M | 37.6M | 32.4M |
| Selling, general and administrative | 262.3M | 77.3M | 80.0M | 71.2M | 75.0M | 45.2M | 32.3M | 27.3M | 19.2M | 21.6M |
| Operating income | 50.9M | -178.5M | 97.1M | 16.0M | 22.3M | 37.0M | 21.7M | 32.6M | 24.5M | 2.03M |
| Depreciation and amortization | 70.0M | 59.0M | 45.6M | 38.7M | 19.6M | 11.1M | 4.81M | 4.34M | 4.38M | 3.71M |
| EBITDA | 120.9M | -119.5M | 142.7M | 54.7M | 41.9M | 48.1M | 26.5M | 37.0M | 28.9M | 5.74M |
| Interest expense | 35.7M | 34.2M | 34.9M | 20.3M | 4.86M | 1.06M | 1.54M | 573.3K | 0 | 2.43M |
| Income before tax | 50.8M | -96.7M | 97.0M | 15.2M | 18.6M | 36.2M | 20.7M | 32.2M | 23.7M | 5.24M |
| Income tax | -232.4K | 17.9M | 47.8M | 2.34M | -3.36M | 5.12M | 1.31M | 1.00M | -416.5K | |
| Net income | 51.1M | -114.6M | 88.8M | 17.5M | 22.0M | 31.0M | 19.4M | 31.2M | 24.1M | 5.24M |
| Earnings per share, basic | 0.13 | -0.28 | 0.22 | 0.04 | 0.05 | 0.08 | 0.05 | 0.09 | 0.07 | 0.02 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 347.6M | 375.2M | 375.4M | 508.6M | 300.2M | 318.7M | 376.1M | 131.3M | 102.5M | 108.6M |
| Short-term investments | 295.3M | 94.1M | 216.7M | 291.1M | 82.1M | 261.9M | 4.02M | 41.8M | 167.9M | 101.5M |
| Receivables | 287.0M | 178.4M | 221.5M | 154.8M | 122.9M | 41.5M | 81.3M | 50.4M | 30.2M | -104.2M |
| Inventory | 57.7M | 40.8M | 47.1M | 28.5M | 15.4M | 12.4M | 11.0M | 8.45M | 9.17M | 3.84M |
| Current assets | 1.18B | 1.08B | 1.13B | 1.18B | 638.8M | 769.1M | 1.07B | 233.5M | 310.8M | 226.0M |
| Property, plant and equipment | 699.0M | 586.3M | 380.0M | 281.5M | 183.1M | 47.2M | ||||
| Total assets | 3.65B | 3.25B | 3.20B | 2.90B | 1.89B | 1.73B | 1.69B | 716.3M | 656.0M | 403.1M |
| Accounts payable | 3.78M | 2.19M | 9.03M | 323.5K | 2.23M | 3.54M | 221.9K | 69.2K | 3.94M | 80.6K |
| Current liabilities | 843.9M | 451.3M | 390.8M | 540.5M | 293.8M | 146.9M | 137.3M | 81.5M | 76.7M | 111.6M |
| Long-term debt | 1.04B | 1.09B | 899.2M | 598.0M | 4.88M | 22.8M | 36.9M | 87.5M | 65.0M | 30.0M |
| Total debt | 1.20B | 1.04B | 810.1M | 151.5M | 60.0M | 104.8M | 87.5M | 75.0M | 30.0M | |
| Total liabilities | -1.66B | 1.67B | 1.49B | 1.32B | 476.8M | 232.4M | 245.1M | 239.4M | 205.5M | 189.7M |
| Shareholders' equity | 1.66B | 1.58B | 1.59B | 1.52B | 1.42B | 1.49B | 1.45B | 476.9M | 450.6M | 213.4M |
| Shares outstanding | 408.0M | 408.0M | 408.3M | 406.6M | 409.7M | 410.1M | 376.4M | 359.9M | 348.7M | 330.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 97.0M | 76.1M | -143.2M | 43.3M | 124.8M | 93.6M | -24.6M | 22.8M | 2.73M | 59.8M |
| Capital spending | -178.6M | -268.5M | -229.0M | -400.2M | -288.5M | -336.3M | -133.0M | -140.7M | -132.8M | -65.8M |
| Free cash flow | -81.6M | -192.4M | -386.3M | -356.9M | -163.7M | -242.6M | -157.6M | -118.0M | -130.1M | -6.04M |
| Cash from investing | -296.0M | -389.1M | -801.7M | -30.6M | -108.7M | -721.5M | -13.3M | -196.1M | -135.6M | |
| Cash from financing | 175.4M | 382.6M | 861.3M | -63.3M | -45.4M | 950.2M | 18.0M | 192.2M | 141.6M | |
| Dividends paid | -31.7M | -27.6M | -18.7M | -12.2M | -4.22M | -3.28M | -1.48M | -549.9K | -2.32M | -3.49M |
| Share buybacks | -15.0M | -3.80M | -155.5M | |||||||
| Change in cash | -222.5M | -44.1M | -148.6M | 115.1M | 28.6M | -64.5M | 204.8M | 28.8M | -3.43M | 68.1M |
Filings
All 84 filings
Cap table
Built by 6ix from Shenzhen Chipscreen Biosciences Co. Ltd. Class A’s releases
- Common shares
- 442,941,642
- Fully diluted
- 442,941,642
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 442,941,642 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 442,941,642 |
Log in to ask 6ix AI your own questions about Shenzhen Chipscreen Biosciences Co. Ltd.